Papillary urothelial neoplasm of low malignant potential in a pediatric renal transplant recipient (PUNLMP): A case report

Pediatric Transplantation

Volumn 11, Issue 6, 2007, Pages 680-682

  Alam, Shumyle ^a   Goebel, Jens ^a   Pacheco, M Cristina ^a   Sheldon, Curtis ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Immunosuppression; Malignancy; Pediatric renal transplant

Indexed keywords

CREATININE;

ARTICLE; BRANCHIOOTORENAL SYNDROME; CASE REPORT; CONTRAST RADIOGRAPHY; CREATININE BLOOD LEVEL; CYSTOSCOPY; FEMALE; GRAFT RECIPIENT; HEMODIALYSIS; HUMAN; KIDNEY GRAFT; PAPILLARY UROTHELIAL NEOPLASM; SCHOOL CHILD; ULTRASOUND; URINARY TRACT INFECTION; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; CHILD; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; URINARY BLADDER NEOPLASMS;

EID: 34547433601     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00717.x     Document Type: Article

References (14)

1. Rodriguez A, Burday D, Sexton W, Ahmed N, Pow-Sang JM. Urothelial carcinoma in a child. Arch Esp Urol 2005 : 58 : 5 473.
2. Hoenig D, McRae S, Chen S, Diamond D, Rabinowitz R, Caldamone A. Transitional cell carcinoma of the bladder in the pediatric patient. J Urol 1996 : 156 : 203 205.
3. Diller R, Gruber A, Wolters H, Senninger N, Spiegel H. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation. Transp Proc 2005 37 : 2089 2092.
4. Muruve N, Shoskes D. Genitourinary malignancies in solid organ transplant recipients. Transplantation 2005 : 80 : 709 715.
5. Buell JF, Gross TG, Thomas MJ, et al. Malignancy in pediatric transplant recipients. Semin Pediatr Surg 2006 : 15 : 179 187.
6. U.S. Renal Data System. USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States, Bethesda MD : National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2003.
7. Fine S, Humphrey P, Dehner L, Amin M, Epstein J. Urothelial neoplasms in patients 20 years or younger: A clinicopathological analysis using World Health Organization 2004 Bladder Consensus Classification. J Urol 2005 174 : 1976 1980
8. Cheng L, Neuman RM, Bostwick DG. Papillary urothelial neoplasms of low malignant potential. Clinical and biological implications. Cancer 1999 : 86 : 2102.
9. Groothoff JW. Long-term outcomes of children with end-stage renal disease. Pediatric Nephrol 2005 : 20 : 849 853.
10. Rubio-Viqueira B, Hidalgo M. Targeting mTOR for cancer treatment. Curr Opin Investig Drugs. 2006 : 7 : 501 512.
11. Samaratunga H, Makarov DV, Epstein JI. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. Urology, 2002 : 60 : 315.
12. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson S. Stage progression in ta papillary urothelial tumors: Relationship to grade, immuniohistochemical expression of tumor markers, mitotic frequency and DNA ploidy, J Urol 2001 : 165 : 1124 1130.
13. Pich A, Chiusa L, Formicioni A, et al. Proliferative activity is the most significant predictor of recurrence in noninvasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 2002 : 95 : 784.
14. Fuji Y, Kawakami S, Koga F, Nemoto T, Kihari K. Long-term outcomes of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003 : 92 : 559.